Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to 0.83.

  • bioAffinity Technologies' Asset Utilization Ratio fell 41.37% to 0.83 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83, marking a year-over-year decrease of 41.37%. This contributed to the annual value of 1.27 for FY2024, which is 411.88% up from last year.
  • bioAffinity Technologies' Asset Utilization Ratio amounted to 0.83 in Q3 2025, which was down 44.25% from 1.49 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Asset Utilization Ratio high stood at 1.49 for Q2 2025, and its period low was -0.10 during Q1 2023.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.83 (2025), whereas its average is 0.77.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 39,727.83% in 2024, then plummeted by 41.37% in 2025.
  • Over the past 3 years, bioAffinity Technologies' Asset Utilization Ratio (Quarterly) stood at 0.28 in 2023, then soared by 420.91% to 1.43 in 2024, then tumbled by 41.37% to 0.83 in 2025.
  • Its Asset Utilization Ratio stands at 0.83 for Q3 2025, versus 1.49 for Q2 2025 and 1.46 for Q1 2025.